Syntonix Pharmaceuticals syntnx.com


Public lists: Pharma Startups (4732)

Syntonix specializes in the discovery and development of therapeutic proteins for treatment of chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders.

Syntonix specializes in the discovery and development of therapeutic proteins for treatment of chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders.

Company (Acquired)

Phone: 781-547-6000

Fax:

9 Fourth Avenue

Waltham, 02451
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Syntonix Pharmaceuticals $49.6M Jan 23, 2007
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Syntonix Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antibodies to fern and uses thereof Jan 30, 2014 Feb 16, 2016 Patent
Immunoglobulin chimeric monomer-dimer hybrids Nov 02, 2012 Jan 13, 2015 Patent
Clotting factor-fc chimeric proteins to treat hemophilia Mar 11, 2013 Aug 26, 2014 Patent
Fc receptor binding proteins Sep 14, 2012 Aug 26, 2014 Patent
Clotting factor-fc chimeric proteins to treat hemophilia Nov 18, 2010 May 28, 2013 Patent
See all 14 patents